News Conference News ACC 2020 PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years Michael O'Riordan March 30, 2020
News Conference News ACC 2020 Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes Yael L. Maxwell March 30, 2020
News Conference News ACC 2020 Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach Todd Neale March 28, 2020
News Daily News COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients Todd Neale March 27, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Daily News PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching Shelley Wood February 19, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2019 Shelley Wood December 31, 2019
News Daily News NOBLE at 5 Years: New Data Favor CABG for Left Main Disease Todd Neale December 23, 2019
News Daily News FDA Approves Icosapent Ethyl for Reducing CVD Events Michael O'Riordan December 13, 2019
News Conference News AHA 2019 Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE Yael L. Maxwell November 21, 2019
News Conference News AHA 2019 Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT Yael L. Maxwell November 17, 2019
News Opinion Off Script AHA 2019 Off Script: Will ISCHEMIA Answer Our Most Pressing Questions? Ajay Kirtane, MD, SM November 12, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Conference News TCT 2019 Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE Michael O'Riordan September 30, 2019
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News TCT 2019 TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off Shelley Wood September 26, 2019